Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Human SAK related to the PLK/polo family of cell cycle kinases shows high mRNA expression in testis.

Karn T, Holtrich U, Wolf G, Hock B, Strebhardt K, Rubsamenwaigmann H.

Oncol Rep. 1997 May-Jun;4(3):505-10.

PMID:
21590086
2.

Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation.

Ando K, Ozaki T, Yamamoto H, Furuya K, Hosoda M, Hayashi S, Fukuzawa M, Nakagawara A.

J Biol Chem. 2004 Jun 11;279(24):25549-61. Epub 2004 Mar 15.

3.

p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.

Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q.

J Biol Chem. 2004 May 14;279(20):21183-92. Epub 2004 Mar 11.

4.

Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells.

Robinson M, Jiang P, Cui J, Li J, Wang Y, Swaroop M, Madore S, Lawrence TS, Sun Y.

Cancer Biol Ther. 2003 Jul-Aug;2(4):406-15.

PMID:
14508115
5.

Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells.

Burns TF, Fei P, Scata KA, Dicker DT, El-Deiry WS.

Mol Cell Biol. 2003 Aug;23(16):5556-71.

6.

AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.

Li J, Jiang P, Robinson M, Lawrence TS, Sun Y.

Carcinogenesis. 2003 May;24(5):827-34.

PMID:
12771025
7.

Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).

Masuda Y, Nishida A, Hori K, Hirabayashi T, Kajimoto S, Nakajo S, Kondo T, Asaka M, Nakaya K.

Oncogene. 2003 Feb 20;22(7):1012-23.

PMID:
12592388
8.

Tissue-specific induction of p53 targets in vivo.

Fei P, Bernhard EJ, El-Deiry WS.

Cancer Res. 2002 Dec 15;62(24):7316-27.

9.

p53-dependent downregulation of metastasis-associated laminin receptor.

Modugno M, Tagliabue E, Ardini E, Berno V, Galmozzi E, De Bortoli M, Castronovo V, Ménard S.

Oncogene. 2002 Oct 24;21(49):7478-87.

10.

SSRP1 functions as a co-activator of the transcriptional activator p63.

Zeng SX, Dai MS, Keller DM, Lu H.

EMBO J. 2002 Oct 15;21(20):5487-97. Erratum in: EMBO J. 2004 Apr 7;23(7):1679.

11.

The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization.

Leung GC, Hudson JW, Kozarova A, Davidson A, Dennis JW, Sicheri F.

Nat Struct Biol. 2002 Oct;9(10):719-24.

PMID:
12352953
12.

Polo-like kinases and centrosome regulation.

Dai W, Wang Q, Traganos F.

Oncogene. 2002 Sep 9;21(40):6195-200. Review. No abstract available.

13.
14.
15.

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

Spänkuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmüller M, von Minckwitz G, Kaufmann M, Strebhardt K.

Oncogene. 2002 May 9;21(20):3162-71.

16.
17.

Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity.

Wang Q, Xie S, Chen J, Fukasawa K, Naik U, Traganos F, Darzynkiewicz Z, Jhanwar-Uniyal M, Dai W.

Mol Cell Biol. 2002 May;22(10):3450-9.

18.

Expression of prostate specific antigen (PSA) is negatively regulated by p53.

Gurova KV, Roklin OW, Krivokrysenko VI, Chumakov PM, Cohen MB, Feinstein E, Gudkov AV.

Oncogene. 2002 Jan 3;21(1):153-7.

19.
20.

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M.

J Biol Chem. 2002 Feb 1;277(5):3247-57. Epub 2001 Nov 19.

Supplemental Content

Support Center